Early-Onset Parkinson's Disease: Unique Features and Management Approaches.

Area of Science:

• Neurology
• Neuroscience

Background:

• Parkinson's disease (PD) affects individuals across different age groups, with early-onset Parkinson's disease (EOPD) presenting unique clinical and genetic profiles.
• Understanding the distinctions between EOPD (onset 21-50 years) and late-onset Parkinson's disease (LOPD) is vital for effective patient management.

Purpose of the Study:

• To delineate the specific clinical features, genetic risk factors, and therapeutic strategies for EOPD.
• To contrast EOPD with LOPD, highlighting differences in diagnosis, progression, and treatment.
• To identify critical knowledge gaps in EOPD research and clinical care.

Main Methods:

• Comparative analysis of clinical characteristics, risk factors, and treatment outcomes between EOPD and LOPD cohorts.
• Review of current literature on EOPD and LOPD, focusing on diagnostic and therapeutic approaches.
• Identification of unmet needs and research priorities in EOPD.

Main Results:

• EOPD exhibits a higher incidence of monogenic factors, focal dystonia, depression, and anxiety compared to LOPD.
• Patients with EOPD experience slower motor progression and reduced cognitive decline but face a higher risk of delayed diagnosis.
• Treatment for EOPD is complicated by earlier onset of dyskinesias and motor fluctuations, with unique considerations like pregnancy and career impact.

Conclusions:

• Significant differences exist in risk factors, clinical presentation, disease progression, and management requirements between EOPD and LOPD.
• Current research predominantly focuses on LOPD, necessitating a shift towards EOPD-specific studies and clinical trials.
• Tailoring diagnostic and therapeutic strategies, alongside dedicated research efforts, is essential for optimizing care for individuals with EOPD.